ライフサイエンスコーパス: needed to

1 how basic developmental studies have contributed to and are needed to advance clinical goals.

2 s probably inevitable, and novel therapeutic approaches are needed to target dormant tumors.

3 Efficient wide-bandgap (WBG) perovskite solar cells are needed to boost the efficiency of silicon solar cells to beyo

4 e CO2 removal capacities, and low regeneration energies are needed to achieve these separations efficiently at scale.

5 portance of this structure, it is unknown which factors are needed to activate cumulus specific gene expression.

6 Interventions are needed to increase high-intensity statin use and adherence af

7 More reliable methods are needed to determine MGMT activity as DNA methylation, the cur

8 Novel strategies are needed to enhance muscle repair and function and to slow this

9 Future studies are needed to address whether similar mechanisms contribute to th

10 Further studies are needed to better assess its safety and applicability.

11 Further studies are needed to confirm and refine these recommendations.

12 Prospective studies are needed to define the impact of pretransplant sensitization on

13 Further studies are needed to determine the life course progression of these chan

14 Further studies are needed to elucidate the source and epidemiology of PCR riboty

15 However, further studies are needed to evaluate whether the control of metabolic parameter

16 by program director attitudes, although larger studies are needed to further define program factors affecting attrition.

17 Additional high-quality interventional studies are needed to further evaluate the effectiveness of patient- and

18 More studies are needed to investigate the use of bone turnover markers for as

19 the pentamer, three anaesthetic-sensitive rho1 subunits are needed to impart full efficacy to the partial GABA agonists.

20 Better tools are needed to identify patients at high risk of developing HF in

21 Further studies will be needed to assess possible herd immunity effects with meningoc

22 n healthy adult samples may help to identify the biomarkers needed to detect nonsymptomatic, preclinical phases of the di

23 ons to effectively deploy registered nurses in primary care needed to assure efficient, evidence-based, and quality healt

24 to recruit the dlPFC, which mediates the cognitive control needed to overcome anxiety and differentiate between old and

25 rd PELDOR measurement, and confirm that lambda < 1/(n-1) is needed to sufficiently suppress multispin effects (with n bei

26 tudinal research with a robust dietary intake assessment is needed to test this hypothesis.

27 Customised service delivery is needed to ensure parity for different geographic and security

28 fects of oxytocin on neural circuits in the hypothalamus is needed to establish the utility of targeting oxytocin signall

29 Reduction of biliary complications, especially ITBL, is needed to improve the outcomes for DCD grafts.

30 neous group of clinical subtypes, and further refinement is needed to improve treatment outcomes.

31 Further research is needed to assess longer-term efficacy and adverse effects.

32 Research is needed to confirm possible interactions of arsenic metabolism

33 Research is needed to inform firm recommendations on how to protect this

34 Further research is needed to investigate the association between these structura

35 Further research is needed to understand how these noncardiac complications may a

36 More research is needed to understand the effectiveness of screening and treat

37 Validation of this novel predictive score is needed to confirm clinical utility.

38 Further study is needed to assess safety and long-term clinical outcome.

39 Innovation in education and training is needed to better prepare future nephrologists for the growing

40 Further work is needed to determine the implications of increased thalamic co

41 United States, potential studies and surveillance platforms needed to fill these gaps, and prioritizing efforts.

42 for at least 3 months (OR = 0.79; CI, 0.62-1.00), and proxy needed to fill out the survey (OR = 0.72; CI, 0.61-0.85) were

43 Here we consider the minimum number of communication rounds needed to perform the locality-constrained tasks of entanglem

44 ticulate both the promise that now exists and what is still needed to bring dramatic and tangible change to patients.-Sco

45 The strategies needed to promote equity in the cardiovascular health of Afri

46 es with novel and defined mechanisms of inhibition are thus needed to functionally characterize V-ATPase and to fully eva

47 Interventions are urgently needed to significantly reduce both mortality and the healthc

48 h in infectious and tropical diseases in Africa is urgently needed to better describe the distribution of pathogen-borne

49 New mosquito control strategies are vitally needed to address established arthropod-borne infectious dise

50 bound IL-6Ralpha (called 'IL-6 cluster signaling' here) was needed to prevent premature induction of interferon-gamma (IF